P2X receptors and acupuncture analgesia.
ATP
Acupuncture analgesia
P2X receptors
Purinergic signaling
Journal
Brain research bulletin
ISSN: 1873-2747
Titre abrégé: Brain Res Bull
Pays: United States
ID NLM: 7605818
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
06
08
2018
revised:
13
10
2018
accepted:
18
10
2018
pubmed:
21
11
2018
medline:
5
8
2020
entrez:
21
11
2018
Statut:
ppublish
Résumé
Purinergic signaling has recently been suggested to constitute the cellular mechanism underlying acupuncture-induced analgesia (AA). By extending the original hypothesis on endogenous opioids being released during AA, Geoffrey Burnstock and Maiken Nedergaard supplied evidence for the involvement of purinoceptors (P2 and P1/A1 receptors) in the beneficial effects of AA. In view of certain pain states (e.g. neuropathic pain) which respond only poorly to therapy with standard analgesics, as well as with respect to the numerous unwanted effects of opioids and non-steroidal anti-inflammatory drugs, it is of great significance to search for alternative therapeutic options. Because clinical studies on AA yielded sometimes heterogeneous results, it is of eminent importance to relay on experiments carried out on laboratory animals, by evaluating the data with stringent statistical methods including comparison with a sufficient number of control groups. In this review, we summarize the state of the art situation with respect to the participation of P2 receptors in AA and try to forecast how the field is likely to move forward in the future.
Identifiants
pubmed: 30458249
pii: S0361-9230(18)30576-8
doi: 10.1016/j.brainresbull.2018.10.015
pii:
doi:
Substances chimiques
Analgesics
0
Anti-Inflammatory Agents, Non-Steroidal
0
Receptors, Purinergic P2X
0
Adenosine Triphosphate
8L70Q75FXE
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
144-152Informations de copyright
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.